DrugPatentWatch Database Preview
Drugs in Development Information for Oglemilast
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Oglemilast?
Oglemilast is an investigational drug.
There have been 4 clinical trials for Oglemilast.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are Forest Laboratories, Glenmark Pharmaceuticals Europe Ltd. (R&D), and [disabled in preview].
Summary for Oglemilast
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 74 |
| WIPO Patent Applications | 37 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2006-05-01) |
| Vendors | 37 |
Recent Clinical Trials for Oglemilast
| Title | Sponsor | Phase |
|---|---|---|
| A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma | Glenmark Pharmaceuticals Europe Ltd. (R&D) | Phase 2 |
| Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Forest Laboratories | Phase 2 |
| Study of Oglemilast for the Prevention of Asthma. | Forest Laboratories | Phase 2 |
Clinical Trial Summary for Oglemilast
Top disease conditions for Oglemilast
Top clinical trial sponsors for Oglemilast
US Patents for Oglemilast
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
